Literature DB >> 27992886

PTSD prevalence among Polish World War II survivors.

Maja Lis-Turlejska1, Aleksandra Łuszczyńska2, Szymon Szumiał3.   

Abstract

OBJECTIVES: Over the past decade research has been published in several Western European countries on the prevalence of PTSD among World War II survivors, mostly civilians. Prevalence rates ranged from 1.9% to 10.8 %. The aim of the study was to measure the frequency of PTSD occurrence among Polish WWII survivors.
METHODS: Data from 96 persons: 59 women and 37 men, aged 70-96 were analyzed. All participants were born before 1945. They completed Polish adaptations of: Posttraumatic Diagnostic Scale (PDS), Impact of Events Scale (IES), Beck's Depression Inventory (BDI) and WWII trauma related questionnaire.
RESULTS: Prevalence rate of potential PTSD was 32,3% Mean values of both number and severity of symptoms of PTSD were significantly higher for respondents with at least one war related trauma comparing to the participants who did note relate any such trauma.
CONCLUSIONS: Comparing to other studies on WWII related PTSD the prevalence rate of possible PTSD was very high. Looking for possible explanation of such results seems to be an important challenge.

Entities:  

Keywords:  PTSD; World War II; posttraumatic stress disorder; prevalence; war trauma

Mesh:

Year:  2016        PMID: 27992886     DOI: 10.12740/PP/OnlineFirst/60171

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  2 in total

1.  Posttraumatic stress symptoms among Polish World War II survivors: the role of social acknowledgement.

Authors:  Maja Lis-Turlejska; Szymon Szumiał; Iwona Drapała
Journal:  Eur J Psychotraumatol       Date:  2018-01-26

2.  Long-Term Psychological Consequences of World War II Trauma Among Polish Survivors: A Mixed-Methods Study on the Role of Social Acknowledgment.

Authors:  Marcin Rzeszutek; Maja Lis-Turlejska; Aleksandra Krajewska; Amelia Zawadzka; Michał Lewandowski; Szymon Szumiał
Journal:  Front Psychol       Date:  2020-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.